Parkinson's Disease Treatment Market Report by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO Inhibitors, COMT Inhibitors, Anticholinergics, and Others), Route of Administration (Oral, Transdermal, Subcutaneous, Intestinal Infusion, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033

Parkinson's Disease Treatment Market Report by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO Inhibitors, COMT Inhibitors, Anticholinergics, and Others), Route of Administration (Oral, Transdermal, Subcutaneous, Intestinal Infusion, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A2792

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Parkinson’s Disease Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Carbidopa/Levodopa
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Dopamine Receptor Agonists
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    MAO Inhibitors
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    COMT Inhibitors
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Anticholinergics
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7   Market Breakup by Route of Administration
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Transdermal
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Subcutaneous
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Intestinal Infusion
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Pharmacies
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    AbbVie Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Acadia Pharmaceuticals Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio 
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
        14.3.4    F. Hoffmann-La Roche AG
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 SWOT Analysis
        14.3.5    GlaxoSmithKline Plc
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio 
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    H. Lundbeck A/S 
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Merck & Co. Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio 
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Mylan N.V.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Novartis AG
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio 
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Orion Corporation
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio 
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Sun Pharmaceutical Industries Ltd.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio 
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Teva Pharmaceutical Industries
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio 
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis
        14.3.13    Wockhardt Ltd. 
           14.3.13.1 Company Overview
           14.3.13.2 Product Portfolio 
           14.3.13.3 Financial

List of Figures

Figure 1: Global: Parkinson’s Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Parkinson’s Disease Treatment Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Parkinson’s Disease Treatment Market: Breakup by Drug Class (in %), 2024
Figure 4: Global: Parkinson’s Disease Treatment Market: Breakup by Route of Administration (in %), 2024
Figure 5: Global: Parkinson’s Disease Treatment Market: Breakup by Distribution Channel (in %), 2024
Figure 6: Global: Parkinson’s Disease Treatment Market: Breakup by Region (in %), 2024
Figure 7: Global: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 8: Global: Parkinson’s Disease Treatment (Carbidopa/Levodopa) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Parkinson’s Disease Treatment (Carbidopa/Levodopa) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Parkinson’s Disease Treatment (Dopamine Receptor Agonists) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Parkinson’s Disease Treatment (Dopamine Receptor Agonists) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Parkinson’s Disease Treatment (MAO Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Parkinson’s Disease Treatment (MAO Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Parkinson’s Disease Treatment (COMT Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Parkinson’s Disease Treatment (COMT Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Parkinson’s Disease Treatment (Anticholinergics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Parkinson’s Disease Treatment (Anticholinergics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Parkinson’s Disease Treatment (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Parkinson’s Disease Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Parkinson’s Disease Treatment (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Parkinson’s Disease Treatment (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Parkinson’s Disease Treatment (Transdermal) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Parkinson’s Disease Treatment (Transdermal) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Parkinson’s Disease Treatment (Subcutaneous) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Parkinson’s Disease Treatment (Subcutaneous) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Parkinson’s Disease Treatment (Intestinal Infusion) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Parkinson’s Disease Treatment (Intestinal Infusion) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Parkinson’s Disease Treatment (Other Routes of Administration) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Parkinson’s Disease Treatment (Other Routes of Administration) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Parkinson’s Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Parkinson’s Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Parkinson’s Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Parkinson’s Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Parkinson’s Disease Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Parkinson’s Disease Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: North America: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: North America: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: United States: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: United States: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Canada: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Canada: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Asia Pacific: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Asia Pacific: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: China: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: China: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Japan: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Japan: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: India: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: India: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: South Korea: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: South Korea: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Australia: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Australia: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Indonesia: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Indonesia: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Others: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Others: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Europe: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Europe: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Germany: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Germany: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: France: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: France: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: United Kingdom: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: United Kingdom: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Italy: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Italy: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Spain: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Spain: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Russia: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Russia: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Others: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Others: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Latin America: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Latin America: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Brazil: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Brazil: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Mexico: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Mexico: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Others: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Others: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Middle East and Africa: Parkinson’s Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Middle East and Africa: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Global: Parkinson’s Disease Treatment Industry: SWOT Analysis
Figure 85: Global: Parkinson’s Disease Treatment Industry: Value Chain Analysis
Figure 86: Global: Parkinson’s Disease Treatment Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Parkinson’s Disease Treatment Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Parkinson’s Disease Treatment Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 3: Global: Parkinson’s Disease Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 4: Global: Parkinson’s Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 5: Global: Parkinson’s Disease Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Parkinson’s Disease Treatment Market Structure
Table 7: Global: Parkinson’s Disease Treatment Market: Key Players

Parkinson's Disease Treatment Market Report by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO Inhibitors, COMT Inhibitors, Anticholinergics, and Others), Route of Administration (Oral, Transdermal, Subcutaneous, Intestinal Infusion, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials